Vertex Pharmaceuticals (VRTX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vertex Pharmaceuticals (VRTX)

VRTX 441.36

+0.6%

Jan 16 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Casaubon who wrote (340)	11/8/1999 7:00:00 PM
From: scaram(o)uche	Read Replies (1) of 1169

>> This is what I consider the most problematic data presented for VX-497, so far. << What works, works. Ribavirin does the trick in combination with IFN, correct? How does it (Ribavirin) do on its own? It's sort of like the old Oldstone studies with LCM.... if you haven't got inflammation, you haven't got disease. Going to be interesting.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next